ANALISIS BIAYA MEDIS LANGSUNG DAN TARIF INA-CBG’s PASIEN DIABETES MELITUS TIDAK TERGANTUNG INSULIN DI RSUD ANUTAPURA PALU
DOI:
https://doi.org/10.36387/jiis.v8i3.1667Keywords:
cost analysis, direct medical cost, diabetes mellitus, INA-CBG'sAbstract
Diabetes mellitus is a long-term disease with an increasing prevalence. Diabetes mellitus is one of the main causes of human morbidity and death and has a significant impact on health financing. Indonesia itself has implemented a national health insurance program that prioritizes effectiveness and cost efficiency. This study aims to determine the average direct medical costs, INA-CBG's rates, the suitability of direct medical costs and INA-CBG's as well as the influence of treatment class, severity, number of secondary diagnoses, and length of stay on the direct medical costs of diabetes mellitus patients at Anutapura Hospital Palu. This research is a descriptive observational study with retrospective data collection from medical records and files detailing patient care costs at Anutapura Hospital Palu in 2020 from the hospital's perspective. The sample used was BPJS inpatients with a primary diagnosis of type 2 diabetes or non-insulin dependent diabetes mellitus (DMTTI) who met the inclusion and exclusion criteria, totaling 132 patients. Data were analyzed descriptively and to see the influence of variables on total costs, the Independent sample t-test and Mann-Whitney test were used. The research results show that the average direct medical costs are IDR 2,751,449, the average INA-CBG's rate is IDR 4,505,508, so there is a mismatch between direct medical costs and INA CBG's. There is a significant influence partially or simultaneously and in a positive direction from the variables treatment class, severity, number of secondary diagnoses, and length of stay on direct medical costs.
References
Agiwahyuanto, F., Widianawati, E., Ratna Wulan, W., Basuki Putri, R., & Artikel, I., 2020, Tarif Rumah Sakit Dengan Tarif Ina-Cbgs Pasien Rawat Inap, Higeia; 4(207), 520–532.
Ambianti, N., Andayani, T. M., & Sulistiawaty, E., 2019, Analisis Biaya Penyakit Diabetes Melitus Sebagai Pertimbangan Perencanaan Pembiayaan Kesehatan, Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal), 5(1), 73–83. https://doi.org/10.22487/j24428744.2019.v5.i1.12071
American Diabetes Association, 2020, Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care, 43(Suppl 1), S14–S31. https://doi.org/doi: 10.2337/dc20-S002
Amir, H., Azwar, M. I., & Ratnaningish, M., 2018, Kejadian Diabetes Melitus (Study Analitik Pada Pasien Rawat Jalan di Rumah Sakit Labuang Baji Makassar), Journal Health Community Empowerment, 1(2).
Anggriani, Y., Rianti, A., Pratiwi, A. N., & Khairani, S., 2018, Evaluasi Biaya Pengobatan Pada Pasien Diabetes Melitus Tipe 2 Rawat Jalan dengan Terapi Insulin di RSUP X di Jakarta Periode Januari 2016-Desember 2017, Pharmaceutical Journal of Indonesia; 4(2), 91–97.
Baroroh, F., Solikah, W. Y., & Urfiyya, Q. A., 2016, Analisis Biaya Terapi Diabetes Melitus Tipe 2 Di Rumah Sakit PKU Muhammadiyah Bantul Yogyakarta, Jurnal Farmasi Sains Dan Praktis; I(2), 11–22.
Dwidayati, A., 2016, Analisis Kesesuaian Biaya Riil Terhadap Tarif INA-CBGs Pada Pengobatan Stroke Non Hemoragik Pasien JKN Rawat Inap RSUD dr. Soehadi Prijonegoro Sragen Tahun 2015, Thesis, Universitas Setia Budi, Surakarta.
Erilisanawati, E., & Werdani, K. E, 2018, Perbedaan Tingkat Kepuasan Pasien Rawat Inap Berdasrkan Kelas Perawatan Di RSUD Dr. Soediran Mangun Sumarso Kabupaten Wonogiri, Skripsi, Universitas Muhammadiyah Surakarta, Surakarta.
Fitri, E., Andayani, T. M., & Suparniati, E., 2015, Cost Analysis of Diabetes Melitus, Journal of Management and Pharmacy Practice, 5(1), 61–66.
Guariguata, L., Whiting, D. R., Hambleton, I., & Beagley, J., 2013, Global Estimates of Diabetes Prevalence for 2013 and Projections for 2035, Diabetes Research and Clinical Practice, 103(2), 137–149.
Heianza, Y., Arase, Y., Kodama, S., Hsieh, S. D., Tsuji, H., Saito, K., Shimano, H., Hara, S., & Sone, H., 2013, Effect of Postmenopausal Status and Age at Menopause on Type 2 Diabetes and Prediabetes in Japanese Individuals: Toranomon Hospital Health Management Center Study 17 (TOPICS 17). Diabetes Care, 36(12), 4007–4014.
International Diabetes Federation, 2019, International Diabetes Federation (IDF) Diabetes Atlas Ninth edition 2019. In The Lancet (Vol. 266, Issue 6881).
Kementerian Kesehatan Republik Indonesia., 2019, Laporan Nasional Riskesdas 2018, In RISKESDAS 2018, Badan Penelitian dan Pengembangan Kesehatan 2019. https://repository.badankebijakan.kemkes.go.id/id/eprint/3514/ - was accessed on Januari 2021.
Khan, M., Hashim, M., King, J., Govender, R., Mustafa, H., & J Al Kaabi., 2020, Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. Epidemiol Glob Health; 10(1), 107–111.
Kristina, S. A. R. I., Endarti, D. W. I., Andayani, T. R. I. M., & Widayanti, A. W., 2020, Direct and Indirect Cost of Diabetes Mellitus in Indonesia: A Prevalence Based Study with Human Capital Approach. International Journal of Pharmaceutical Research; 13(01).
Lubis, I. K., & Susilawati, S., 2018, Analisis Length Of Stay (Los) Berdasarkan Faktor Prediktor Pada Pasien DM Tipe II di RS PKU Muhammadiyah Yogyakarta. Jkesvo (Jurnal Kesehatan Vokasional); 2(2), 161.
Megawati, F., Meriyani, H., Wardani, I. G. A. A. K., & Wintariani, N. P., 2020, Gambaran Biaya Pasien Umum Rawat Inap Diabetes Mellitus Di Rumah Sakit Umum Ari Canti Periode Tahun 2017, Jurnal Ilmiah Medicamento; 5(1), 21–26.
Munawaroh, S., Sulistiadi, W., & Rachmad., 2019, Perbedaan Tarif INA–CBG’s Dengan Tarif Riil Rumah Sakit Pada Pasien BPJS Kasus Stroke Iskemik Rawat Inap Kelas I Di RS PON Tahun 2018, Jurnal Manajemen Dan Administrasi Rumah Sakit Indonesia (MARSI); 3(2), 155–165.
Nisa, B. I., & Raharjo, B. B., 2021, Determinan Selisih Biaya Riil dan Tarif INA CBG’spada Pasien Jantung Koroner. Higeia Journal of Public Health Research and Development; 1(3), 84–94. 8
Oktadiana, I., 2021, Perbandingan Biaya Riil Pada Pasien Diabetes Mellitus Tipe 2 Dengan Tarif INA-CBG ’ S Di Rumah Sakit Umum Daerah, Jurnal Farmasi Tinctura; 2(2), 42–51.
Perkumpulan Endokrinologi Indonesia., 2021, Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021, Penerbit PB. Perkeni, Jakarta.
Rahayuningrum, I. O., Tamtomo, D., & Suryono, A., 2016, Comparison Between Hospital Inpatient Cost and INA-CBGs Tariff of Inpatient Care in the National Health Insurance Scheme in Solo, Boyolali and Karanganyar Districts , Central Java, Journal of Health Policy and Management; 1(2), 102–11.
Ren, Y., Zhang, M., Liu, Y., Sun, X., Wang, B., Zhao, Y., Liu, D., Liu, X., Zhang, D., Liu, F., Cheng, C., Liu, L., Chen, X., Zhou, Q., & Hu, D., 2019, Association of Menopause and Type 2 Diabetes Mellitus, Menopause; 26(3), 325–330.
Suhartoyo, 2018, Perlindungan Hukum Bagi Pekerja Peserta BPJS Kesehatan di Rumah Sakit, Administrative Law & Governance Journal; 1(2), 48–66.
Wijayanti, A. W., & Mahfudz., 2021, Analisis Strategi Rumah Sakit Dalam Menghadapi Era BPJS Kesehatan, Syntax Literate : Jurnal Ilmiah Indonesia; 6(11).
World Health Organisazion., 2016, Global Report on Diabetes. WHO Library Cataloguing in Publication Data. https://www.who.int/publications/i/item/9789241565257
Yuniarti, E., Amalia, A., & Handayani, T. M., 2015, Analisis Biaya Terapi Penyakit Diabetes Melitus Pasien Jaminan Kesehatan Nasional di RS PKU Muhammadiyah Yogyakarta, Jurnal Kebijakan Kesehatan Indonesia; 04(03), 97–103.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Jurnal Ilmiah Ibnu Sina
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
